Clinical Trial Update: Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma

View source ↗

Summary

A post-authorization safety study assessing the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Sonidegib (Sonidegib)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Basal Cell Carcinoma | Status: COMPLETED